Shutdown US : Le Sénat doit valider la proposition des représentants avant minuit
- 169
DAILY FX
Welcome to DailyFX! Your one-stop channel for market news, actionable analysis and strategy, and trading education.
Why Subscribe?
-Cutting edge real-time insight on actionable market developments
-Clearly explained videos to help you build your trading strategy and market knowledge
-Access to self-serve market information for traders to apply and enhance their own analysis
-Quick take videos of market-moving developments throughout the trading week
Millions of traders from around the world seek out DailyFX for up-to-date Forex News & Analysis.
Think of us as your trading friends that happen to have access to institutional level research and years of live trading experience under the belts. We help our traders help themselves by giving you what you need to trade well month after month. Our services are free, and if you want to know how we are compensated, you can find that information here.
Lastest news
- Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
- GRAINGER INCREASES QUARTERLY DIVIDEND BY 10%; REFRESHES SHARE REPURCHASE AUTHORIZATION
- Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New River Valley Plant
- Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study